Jan Boeckhaus

A multicenter, randomized, placebo-controlled, double-blind phase 3 trial with open-arm comparison indicates safety and efficacy of nephroprotective therapy with ramipril in children with Alport’s syndrome

Burkhard Tönshoff, Lutz T. Weber, Lars Pape et al. · Kidney International · 2020 · 140 citations · Full text

Sodium-Glucose Cotransporter-2 Inhibitors in Patients with Hereditary Podocytopathies, Alport Syndrome, and FSGS: A Case Series to Better Plan a Large-Scale Study

Jan Boeckhaus · Cells · 2021 · 35 citations · Full text

Lifelong effect of therapy in young patients with the <i>COL4A5</i> Alport missense variant p.(Gly624Asp): a prospective cohort study

Jan Boeckhaus, Julia Hoefele, Korbinian M. Riedhammer et al. · Nephrology Dialysis Transplantation · 2022 · 29 citations · Full text

Characterization of Sensorineural Hearing Loss in Children with Alport Syndrome

Jan Boeckhaus, Nicola Strenzke, Celine Storz · Life · 2020 · 25 citations · Full text

Protocol and rationale for a randomized controlled SGLT2 inhibitor trial in paediatric and young adult populations with chronic kidney disease: DOUBLE PRO-TECT Alport

Jan Boeckhaus, Lutz T. Weber, Hiddo J.L. Heerspink et al. · Nephrology Dialysis Transplantation · 2024 · 14 citations · Full text